Company: ARTL
Filing Date: 2025-06-13
Form Type: 8-K
Source: 0001640334-25-001046
Chunk: 0

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-06-13
Form: 8-K
Item: Item 3.03
Chunk 0
---
Item 3.03. Material Modification to Rights of Security Holders.

The information set forth in Item 5.03 of this Current Report on Form 8-K is incorporated by reference into this Item 3.03. A copy of the Certificate of Change described in Item 5.03 is filed as Exhibit 3.1 to this Current Report on Form 8-K.

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On June 12, 2025, Artelo Biosciences, Inc., a Nevada corporation (the “ Company”), filed with the Secretary of State of the State of Nevada a Certificate of Change (the “ Certificate of Change”), pursuant to Nevada Revised Statutes 78.209, to effect a one-for-six (1-for-6) reverse stock split (the “ Reverse Split”) of the Company’s issued and outstanding common stock, par value $0.001 per share (the “ Common Stock”). The Reverse Split will be effective as of 12:01 a. m. Eastern Time on June 13, 2025 (the “ Effective Time”). Pursuant to the Nevada Revised Statutes 78.207, the Company’s board of directors has the authority to effect a reverse stock split without stockholder approval if the number of authorized shares of common stock and the number of outstanding shares of common stock are proportionally reduced.

As a result of the Reverse Split, each six (6) pre-split shares of Common Stock outstanding will automatically combine into one (1) new share of Common Stock without any action on the part of the holders, and the number of outstanding shares of Common Stock will be reduced from 3,280,000 to approximately 546,667. The number of authorized shares of common stock has been reduced from 50,000,000 to 8,333,333, while the number of authorized shares of preferred stock has been reduced from 416,667 to 69,444. The new CUSIP number for the Common Stock following the Reverse Split will be 04301G607.

The Reverse Split is being effected in order to improve the marketability and liquidity of the Company’s common stock and to regain compliance with all of the continued listing requirements of the Nasdaq Stock Market (“ Nasdaq”).

No fractional shares will be issued as a result of the Reverse Split. Stockholders who otherwise would be entitled to a fractional share because they hold a number of shares not evenly divisible by the 1 (